Using the incidence of bacterial sexually transmitted infection (STI) as a surrogate for condomless sexual behavior, we assessed the association between STI and uncontrolled HIV replication among in-care persons with HIV (PWH) enrolled in a longitudinal HIV cohort study in the District of Columbia (the DC Cohort). Although STI occurrence initially correlated with higher HIV viral load (VL), this difference became more attenuated over time (2012–2016). This was true overall and among those with the greatest number of STIs [age 18–34, men who have sex with men (MSM)]. This likely reflects gains in population-wide virologic control through improved antiretroviral therapy and access to care, which helps mitigate the risk of HIV transmission.
This is a preview of subscription content,to check access.
Access this article
The authors confirm that the data that supports the findings of this study are available in the article and the supplementary materials.
Centers for Diseases Control and Prevention (CDC). STD diagnosis among key US populations: 5-year trends. CDC. 2018. Available at: https://npin.cdc.gov/publication/std-diagnosis-among-key-us-populations-5-year-trends. Accessed 24 May 2021.
District of Columbia Department of Health (DC DOH). “HIV/AIDS, Hepatitis, STD, and TB Administration. Annual epidemiology & surveillance report—data through December 2019.” DC DOH, 2020. Available at: https://dchealth.dc.gov/publication/hahsta-annual-epidemiology-and-surveillance-report. Accessed 24 May 2021.
DC DOH. “DC ends HIV: defining our goal.” 2020. https://www.dcendshiv.org/our-plan/defining-our-goal. Accessed 24 May 2021.
Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(Suppl 3):5–7. https://doi.org/10.1016/s0140-6736(98)90002-2.
Jones J, Weiss K, Mermin J, et al. Proportion of incident human immunodeficiency virus cases among men who have sex with men attributable to gonorrhea and chlamydia: a modeling analysis. Sex Transm Dis. 2019;46(6):357–63. https://doi.org/10.1097/OLQ.0000000000000980.
Secco AA, Akselrod H, Czeresnia J, DC Cohort Executive Committee, et al. Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort. Sex Transm Infect. 2020;96(2):89–95. https://doi.org/10.1136/sextrans-2019-054216.
Lucar J, Hart R, Rayeed N, DC Cohort Executive Committee, et al. Sexually transmitted infections among HIV-infected individuals in the District of Columbia and estimated HIV transmission risk: data from the DC Cohort. Open Forum Infect Dis. 2018;5(2):ofy017. https://doi.org/10.1093/ofid/ofy017.
Mayer KH, de Vries HJ. HIV and sexually transmitted infections: reconciling estranged bedfellows in the U = U and PrEP era. J Int AIDS Soc. 2019;22 Suppl 6(Suppl Suppl 6):e25357. https://doi.org/10.1002/jia2.25357.
U.S. White House. 2021. National HIV/AIDS strategy for the United States 2022–2025. Washington, DC. Available at: https://www.hiv.gov/federal-response/national-hiv-aids-strategy/national-hiv-aids-strategy-2022-2025. Accessed 5 Apr 2022.
DC Cohort Longitudinal HIV Study. http://go.gwu.edu/dccohort. Accessed 24 May 2021.
Castel AD, Terzian A, Opoku J, DC Cohort Executive Committee, et al. Defining care patterns and outcomes among persons living with HIV in Washington, DC: linkage of clinical cohort and surveillance data. JMIR Public Health Surveill. 2018;4(1):e23. https://doi.org/10.2196/publichealth.9221.
Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9. https://doi.org/10.1056/NEJMoa1600693.
Doshi RK, Li J, Dorsey K, Allston A, Kharfen M. Earlier diagnoses and faster treatment of HIV in the District of Columbia: HIV surveillance analysis, 2006–2016. AIDS Care. 2019;31(12):1476–83. https://doi.org/10.1080/09540121.2019.1595516.
Opoku J, Doshi RK, Castel AD, et al. Comparison of clinical outcomes of persons living with HIV by enrollment status in Washington, DC: evaluation of a large longitudinal HIV cohort study. JMIR Public Health Surveill. 2020;6(2): e16061. https://doi.org/10.2196/16061.
We would like to thank the site Principal Investigators, Research Assistants, the Community Advisory Board, the patients themselves, the DC Department of Health, and the National Institutes of Health (NIH) for their contributions to the DC Cohort. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Data in this manuscript were collected by the DC Cohort Study Group with investigators and research staff located at: Children’s National Medical Center Adolescent (Lawrence D’Angelo) and Pediatric (Natella Rakhmanina) clinics; The Senior Deputy Director of the DC Department of Health HAHSTA (Michael Kharfen); Family and Medical Counseling Service (Michael Serlin); Georgetown University (Princy Kumar); The George Washington University Biostatistics Center (Vinay Bhandaru, Tsedenia Bezabeh, Nisha Grover-Fairchild, Lisa Mele, Susan Reamer, Alla Sapozhnikova, Greg Strylewicz, Marinella Temprosa, Naji Younes, and Kevin Xiao); The George Washington University Department of Epidemiology (Morgan Byrne, Amanda Castel, Alan Greenberg, Maria Jaurretche, Paige Kulie, Anne Monroe, James Peterson, Bianca Stewart, and Brittany Wilbourn) and Department of Biostatistics and Bioinformatics (Yan Ma); The George Washington University Medical Faculty Associates (Hana Akselrod); Howard University Adult Infectious Disease Clinic (Jhansi L. Gajjala) and Pediatric Clinic (Sohail Rana); Kaiser Permanente Mid-Atlantic States (Michael Horberg); La Clinica Del Pueblo (Ricardo Fernandez); MetroHealth (Annick Hebou); National Institutes of Health (Carl Dieffenbach, Henry Masur); Washington Health Institute, formerly Providence Hospital (Jose Bordon); Unity Health Care (Gebeyehu Teferi); Veterans Affairs Medical Center (Debra Benator); Washington Hospital Center (Maria Elena Ruiz); and Whitman-Walker Institute (Stephen Abbott).
The DC Cohort is funded by the National Institute of Allergy and Infectious Diseases, UM1 AI069503 and 1R24AI152598-01. This research was supported by the District of Columbia Center for AIDS Research, an NIH funded program (AI117970), which is supported by the following NIH CoFunding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Conflict of interest
The authors declare that they have no conflict of interest.
IRB APPROVAL: #071029 George Washington University IRB.
Consent to Participate
Participants in the DC Cohort consent to have their demographic and clinical data electronically and manually abstracted from medical records at the participating sites, entered into a centralized database and linked to DC Department of Health HIV/AIDS, Hepatitis, STD, TB Administration (DC HAHSTA) surveillance databases.
Consent for Publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Akselrod, H., Byrne, M., Lundberg, J. et al. Improvements in Virologic Control Among PWH Over Time: Narrowing the Gap Between Those With and Without STIs. AIDS Behav 27, 673–677 (2023). https://doi.org/10.1007/s10461-022-03802-6